Budesol 1.25mg/1mg Inhaler

Introduction

The Budesol is a prescription medication that combines two active ingredients: Levosalbutamol and Budesonide. Levosalbutamol is a bronchodilator, while Budesonide is a corticosteroid. This inhaler is used for the management of asthma and chronic obstructive pulmonary disease (COPD). It is available under the brand name Budesol.

Uses

Budesol is prescribed to help control and prevent symptoms such as wheezing, shortness of breath, chest tightness, and coughing in patients with asthma and COPD. It is used as a maintenance treatment to provide long-term relief and reduce the frequency and severity of symptoms.

Dosage and Administration

The dosage of Budesol will depend on the individual’s condition and response to treatment. Follow the instructions provided by your healthcare professional. Generally, the recommended dose for adults and children above 12 years of age is 1 to 2 inhalations twice daily. The inhaler should be shaken well before each use. Rinse your mouth with water after each use to minimize the risk of oral thrush.

Mechanism of Action

Levosalbutamol, one of the active ingredients in Budesol, works by relaxing the muscles in the airways, thereby opening them up and making it easier to breathe. Budesonide, the other active ingredient, is a corticosteroid that reduces inflammation in the airways, helping to prevent asthma and COPD symptoms.

Side Effects

Common side effects may include headache, throat irritation, cough, and hoarseness. These side effects are usually mild and temporary.

Serious side effects are rare but may include increased heart rate, chest pain, tremors, or worsening breathing symptoms. Seek medical attention if any of these occur.

Drug Interactions

inform your healthcare professional about all the medications you are taking, including over-the-counter drugs, vitamins, and herbal supplements. Some medications may interact with Budesol, potentially increasing the risk of side effects or affecting its effectiveness. Common drug interactions may include certain beta-blockers, diuretics, and other inhalers. Your healthcare professional will guide you on potential interactions to be aware of.

Precautions

Before using Budesol, inform your healthcare professional about any allergies, medical conditions, or medications you are currently taking. This medication may not be suitable for everyone, particularly individuals with a history of heart problems, high blood pressure, diabetes, or certain eye conditions. Avoid sudden discontinuation of the medication, as this may lead to worsening of symptoms.

Storage

Budesol should be stored at room temperature, away from direct sunlight and moisture. Keep it out of reach of children and pets. Do not use the inhaler if it has expired or if the seal is broken. Proper storage ensures the medication remains effective and safe to use.

Patient Tips

• Follow the prescribed dosage and administration instructions provided by your healthcare professional.
• Rinse your mouth with water after each use to minimize the risk of oral thrush.
• Keep track of the number of doses used to know when a replacement inhaler is needed.
• Carry the inhaler with you at all times to ensure it is readily available when needed.
• If you experience any new or worsening symptoms, inform your healthcare professional promptly.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Budesonide tablets, capsules and granules: steroid to treat inflammation (NHS UK) [Accessed 26 Jun. 2024] (online) Available at:
• Benacort 64 micrograms Nasal Spray (Health Professionals SmPC) Available at:
• Budesonide (Drugs.com) [Accessed 6 Jun. 2024] (online) Available at:
• albuterol 90 mcg-budesonide 80 mcg/actuation hfa aerosol inhaler (RX) [Accessed 23 Jun. 2024] (online) Available at:
• Budesonide (MedlinePlus) [Accessed 28 Jun. 2024] (online) Available at:
• López-Sanromán A, Clofent J, Garcia-Planella E, Menchén L, Nos P, Rodríguez-Lago I, Domènech E. Reviewing the therapeutic role of budesonide in Crohn’s disease. Gastroenterol Hepatol. 2018 Aug-Sep;41(7):458-471. doi: 10.1016/j.gastrohep.2018.05.013. Epub 2018 Jul 12. [Accessed 3 Jun. 2024] Available at: